Showing results (631-640 of 695) with videos related to

Sort By:
Pageof 70
Disease Models & Mechanisms|January 30, 2023
A novel class of sulphonamides potently block malaria transmission by targeting a Plasmodium vacuole membrane proteinSabrina Yahiya, Charlie N Saunders, Sarah Hassan, et al.
JCI Insight|June 9, 2026
Regulatory B cells contribute to allergen-encapsulating nanoparticle immunotherapy efficacy for food allergyLaila M Rad, Michael N Saunders, Laura A Williams, et al.
Advanced Healthcare Materials|September 28, 2023
Building-Block Size Mediates Microporous Annealed Particle Hydrogel Tube Microenvironment Following Spinal Cord InjuryBrian C Ross, Robert N Kent, Michael N Saunders, et al.
British Journal of Haematology|May 15, 2009
Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromesAndrea Pellagatti, Teresa Marafioti, Jennifer C Paterson, et al.
The Journal of Pathology|June 2, 2006
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomasS Tedoldi, J C Paterson, J Cordell, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2017
Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALSPrajwal Ciryam, Isabella A Lambert-Smith, Daniel M Bean, et al.
Blood|September 15, 2005
Transmembrane adaptor molecules: a new category of lymphoid-cell markersSara Tedoldi, Jennifer C Paterson, Martin-Leo Hansmann, et al.
Scientific Reports|May 11, 2016
Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2Sathya Narayanan Patmanathan, Steven P Johnson, Sook Ling Lai, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 23, 2024
The UK Divide: Does Having a Pembrolizumab-Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab-Chemotherapy Combination in ScotlandA Thapa, A Cowell, A Peters, et al.
The Journal of Pathology|October 9, 2014
Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinomaLee Fah Yap, Sharmila Velapasamy, Hui Min Lee, et al.
Pageof 70